Cure My Disease

Don't miss your cure!

 Log in / Sign up

New obesity drug shows promise in japanese trial

NCT ID NCT06176365

Completed Disease control Sponsor: Boehringer Ingelheim Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new medicine called survodutide for weight loss in 274 Japanese adults with obesity and related health problems like diabetes or high blood pressure. Participants received weekly injections of survodutide or a placebo for about 1.5 years, along with diet and exercise advice. The main goals were to see how much weight they lost and if at least 5% of body weight was reduced.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBESITY

Contacts and locations

Locations

  • Chiba University Hospital

    Chiba, Chiba, 260-8677, Japan

  • Clinical Research Hospital Tokyo

    Tokyo, Shinjuku-ku, 160-0004, Japan

  • Dojinkinenkai Meiwa Hospital

    Tokyo, Chiyoda-ku, 101-0041, Japan

  • Fukuwa Clinic

    Tokyo, Chuo-ku, 104-0031, Japan

  • Gifu University Hospital

    Gifu, Gifu, 501-1194, Japan

  • HS Clinic

    Tokyo, Shinjuku-ku, 169-0072, Japan

  • Hosokawa Surgery Clinic

    Aichi, Nagoya, 453-0812, Japan

  • Ijinkai Takeda General Hospital

    Kyoto, Kyoto, 601-1495, Japan

  • Ikebukuro Metropolitan Clinic

    Tokyo, Toshima-ku, 171-0021, Japan

  • Jiyugaoka Yamada Clinic

    Hokkaido, Obihiro, 080-0848, Japan

  • Kobe University Hospital

    Hyogo, Kobe, 650-0017, Japan

  • Medical Corporation KEISEIKAI Kajiyama Clinic

    Kyoto, Kyoto, 600-8898, Japan

  • Morinagaueno Clinic

    Kumamoto, Kumamoto, 860-0863, Japan

  • Motomachi Takatsuka Naika Clinic

    Kanagawa, Yokohama, 231-0023, Japan

  • Nagoya City University Hospital

    Aichi, Nagoya, 467-8602, Japan

  • New Medical Research System Clinic

    Tokyo, Hachioji, 192-0046, Japan

  • OCROM Clinic

    Osaka, Suita, 565-0853, Japan

  • Osaka Metropolitan University Hospital

    Osaka, Osaka, 545-8586, Japan

  • Saino Clinic

    Saitama, Tokorozawa, 359-1141, Japan

  • Shimamura Kinen Hospital

    Tokyo, Nerima-ku, 177-0051, Japan

  • Shinei Medical Healthcare Clinic

    Tokyo, Suginami-ku, 166-0003, Japan

  • Suidoubashi Medical Clinic

    Tokyo, Chiyoda-ku, 101-0065, Japan

  • ToCROM Clinic

    Tokyo, Shinjyuku-ku, 160-0008, Japan

  • Tokyo Asbo Clinic

    Tokyo, Chuo-ku, 104-0031, Japan

  • Tokyo Center Clinic

    Tokyo, Chuo-ku, 103-0028, Japan

  • Tokyo-Eki Center-building Clinic

    Tokyo, Chuo-ku, 103-0027, Japan

  • Yamasaki Family Clinic

    Hyogo, Amagasaki, 660-0861, Japan

  • Yoshimura Clinic

    Kumamoto, Kumamoto, 861-8039, Japan

More trials for these conditions

Other studies related to the condition(s) this trial covers.